Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rogatti

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1992
Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregationR Katzenschlager, K Weiss, W Rogatti, et al.
Thrombosis Research|July 15, 1997
Platelet response during prostaglandin E1-therapy in patients with non-insulin-dependent diabetes mellitusH Kritz, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1989
Beneficial effect of long-term PGE1-treatment in left ventricular heart failureI Virgolini, J Kaliman, P Fitscha, et al.
Experimental Pathology|January 1, 1990
Additive benefit of PGI2 and PGE1 (via different mechanisms?) on inhibition of activation of human vascular smooth muscle cells?H Sinzinger, P Fitscha, O Wagner, et al.
Progress in Clinical and Biological Research|January 1, 1987
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimensT Simmet, P Fitscha, B A Peskar, et al.
Progress in Clinical and Biological Research|January 1, 1990
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivoH Sinzinger, P Fitscha, F Rauscha, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1995
PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wallM Rodrigues, H Sinzinger, H Kritz, et al.
Lancet (London, England)|March 17, 1990
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular diseaseH Sinzinger, P Fitscha, J O'Grady, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2004
Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemiaS Schellong, E Altmann, P von Bilderling, et al.
Eicosanoids|January 1, 1991
13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administrationP Fitscha, F Rauscha, W Rogatti, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1992
Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregationR Katzenschlager, K Weiss, W Rogatti, et al.
Thrombosis Research|July 15, 1997
Platelet response during prostaglandin E1-therapy in patients with non-insulin-dependent diabetes mellitusH Kritz, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1989
Beneficial effect of long-term PGE1-treatment in left ventricular heart failureI Virgolini, J Kaliman, P Fitscha, et al.
Experimental Pathology|January 1, 1990
Additive benefit of PGI2 and PGE1 (via different mechanisms?) on inhibition of activation of human vascular smooth muscle cells?H Sinzinger, P Fitscha, O Wagner, et al.
Progress in Clinical and Biological Research|January 1, 1987
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimensT Simmet, P Fitscha, B A Peskar, et al.
Progress in Clinical and Biological Research|January 1, 1990
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivoH Sinzinger, P Fitscha, F Rauscha, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1995
PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wallM Rodrigues, H Sinzinger, H Kritz, et al.
Lancet (London, England)|March 17, 1990
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular diseaseH Sinzinger, P Fitscha, J O'Grady, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2004
Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemiaS Schellong, E Altmann, P von Bilderling, et al.
Eicosanoids|January 1, 1991
13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administrationP Fitscha, F Rauscha, W Rogatti, et al.
Pageof 4